EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Teixobactin Analogues Show Promising In Vitro Activity on Biofilm Formation by Staphylococcus aureus and Enterococcus faecalis

Ahmed M Amer, Colin Charnock, Sanko Nguyen

Current Microbiology · 2024

DOI: 10.1007/s00284-024-03857-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Microbiology, 2024. Verfasst von Ahmed M Amer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Health, Oslo Metropolitan University (OsloMet), Pilestredet 50, 0167, Oslo, Norway. ahmedame@oslomet.no. Hauptthemen laut MEDLINE: Biofilms, Enterococcus faecalis, Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: storbyuniversitetet, OsloMet - Oslo Metropolitan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of infections caused by biofilm-forming organisms is challenging. The newly discovered antibiotic teixobactin shows activity against a wide range of biofilm-forming bacteria. However, the laborious and low-yield chemical synthesis of teixobactin complicates its further development for clinical application. The use of more easily synthesized teixobactin analogues may offer promise in this regard. In this article, three newly developed analogues were tested for efficacy against Staphylococcus aureus and Enterococcus faecalis . Minimum inhibitory and -bactericidal concentrations were investigated. MIC values for S. aureus and E. faecalis ranged from 0.5–2 and 2–4 μg/mL, respectively. Moreover, the ability of the analogues to prevent biofilm formation and to inactivate bacterial cells in already established S. aureus biofilm on medical grade materials (PVC and PTFE) used in the production of infusion tubing and catheters were also tested. The analogues showed an ability to prevent biofilm formation and inactivate bacterial cells in established biofilms at concentrations as low as 1–2 μg/mL. Confocal laser scanning microscopy showed that the most promising analogue (TB3) inactivated S. aureus cells in a preformed biofilm and gave a reduction in biovolume. The relative ease of synthesis of the analogues and their in vitro efficacy, makes them promising candidates for pharmaceutical development. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsEnterococcus faecalisStaphylococcus aureusAnti-Bacterial AgentsMicrobial Sensitivity TestsDepsipeptides

Substanzen

Anti-Bacterial AgentsDepsipeptidesteixobactin

Autor:innen und Institutionen

  • Department of Life Sciences and Health, Oslo Metropolitan University (OsloMet), Pilestredet 50, 0167, Oslo, Norway. ahmedame@oslomet.no.
  • Department of Life Sciences and Health, Oslo Metropolitan University (OsloMet), Pilestredet 50, 0167, Oslo, Norway.

Förderung

  • storbyuniversitetet
  • OsloMet - Oslo Metropolitan University

Zitieren

APA

Amer, A. M., Charnock, C., & Nguyen, S. (2024). Novel Teixobactin Analogues Show Promising In Vitro Activity on Biofilm Formation by Staphylococcus aureus and Enterococcus faecalis. Current Microbiology. https://doi.org/10.1007/s00284-024-03857-9

Vancouver

Amer AM, Charnock C, Nguyen S. Novel Teixobactin Analogues Show Promising In Vitro Activity on Biofilm Formation by Staphylococcus aureus and Enterococcus faecalis. Current Microbiology. 2024. doi:10.1007/s00284-024-03857-9

BibTeX
@article{Amer2024,
  author = {Amer, Ahmed M and Charnock, Colin and Nguyen, Sanko},
  title = {Novel Teixobactin Analogues Show Promising In Vitro Activity on Biofilm Formation by Staphylococcus aureus and Enterococcus faecalis},
  journal = {Current Microbiology},
  year = {2024},
  doi = {10.1007/s00284-024-03857-9}
}
Kostenlos starten →